Global Malaria Diagnostics Market - Forecasts from 2018 to 2023

October 2018 | 105 pages | ID: G47DB52280AEN
Knowledge Sourcing Intelligence LLP

Abstracts

The global malaria diagnostic market is projected to grow at a CAGR of 4.01% over the forecast period of 2017-2023. High quality malaria diagnostic kits are important as any misdiagnosis or delay in treatment can result in significant morbidity and mortality. Malaria diagnostics provide early and accurate diagnosis of the disease which is essential for the rapid and effective disease management. As per report by WHO, in 2016, there were an estimated 216 million cases of malaria, an increase of about 5 million cases over 2015. Molecular diagnostics, rapid diagnostic tests (RDTs) are the examples of malaria diagnostic techniques that are frequently used. The growth in the market may be attributed to the advancements in the technology for the rapid detection of the disease. Rise in the government funding regarding the malaria diagnostic research and awareness in developing regions will also boost the market during the given time frame. However, low awareness among the people regarding the malaria diagnostics may restrain the growth of the market during the given forecast period.

This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical region. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.

Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the global malaria diagnostics market value chain. Last step involves complete market engineering which includes analysing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.

Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the global malaria diagnostics market.

Major industry players profiled as part of the report are Motic, Abbott and Meridian Bioscience, Europe among others.

Segmentation

• By Technique
• Rapid Diagnostic Tests (RDTs)
• Microscopy
• Nucleic Acid Detection
• By End-Users
• Hospitals and Clinics
• Diagnostic Centers
• By Geography
• North America
• United States
• Canada
• Others
• South America
• Brazil
• Argentina
• Others
• Europe
• United Kingdom
• Germany
• France
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Israel
• Others
• Asia Pacific
• China
• India
• Australia
• South Korea
• Others

Contents

1. INTRODUCTION

1.1. Market Definition
1.2. Scope of the Study
1.3. Currency
1.4. Assumptions
1.5. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

2.1. Research Design
2.2. Secondary Sources
2.3. Validation

3. KEY FINDINGS OF THE STUDY

4. MARKET DYNAMICS

4.1. Drivers
4.2. Restraints
4.3. Opportunities and Market Trends
4.4. Market Segmentation
4.5. Porter’s Five Forces Analysis
  4.5.1. Bargaining Power of Suppliers
  4.5.2. Bargaining Power of Buyers
  4.5.3. Threat of New Entrants
  4.5.4. Threat of Substitutes
  4.5.5. Competitive Rivalry in the Industry
4.6. Industry Value Chain Analysis
4.7. Industry Regulations
4.8. Scenario Analysis

5. GLOBAL MALARIA DIAGNOSTICS MARKET FORECAST BY TECHNIQUE

5.1. Rapid Diagnostic Tests (RDTs)
5.2. Microscopy
5.3. Nucleic Acid Detection

6. GLOBAL MALARIA DIAGNOSTICS MARKET FORECAST BY END-USER

6.1. Hospitals and Clinics
6.2. Diagnostic Centres

7. GLOBAL MALARIA DIAGNOSTICS MARKET FORECAST BY GEOGRAPHY

7.1. North America
  7.1.1. The U.S
  7.1.2. Canada
  7.1.3. Mexico
  7.1.4. Others
7.2. South America
  7.2.1. Brazil
  7.2.2. Argentina
  7.2.3. Others
7.3. Europe
  7.3.1. U.K.
  7.3.2. France
  7.3.3. Germany
  7.3.4. Italy
  7.3.5. Others
7.4. Middle East and Africa
  7.4.1. Saudi Arabia
  7.4.2. UAE
  7.4.3. Israel
  7.4.4. Others
7.5. Asia Pacific
  7.5.1. China
  7.5.2. India
  7.5.3. Australia
  7.5.4. South Korea
  7.5.5. Others

8. COMPETITIVE INTELLIGENCE

8.1. Market Share Analysis
8.2. Strategies of Key Players
8.3. Recent Investments and Deals

9. COMPANY PROFILES

9.1. Motic
  9.1.1. Overview
  9.1.2. Financials
  9.1.3. Product and Services
  9.1.4. Recent Developments
9.2. Sight
  9.2.1. Overview
  9.2.2. Financials
  9.2.3. Product and Services
  9.2.4. Recent Developments
9.3. BioMérieux SA
  9.3.1. Overview
  9.3.2. Financials
  9.3.3. Product and Services
  9.3.4. Recent Developments
9.4. Intellectual Ventures Laboratory
  9.4.1. Overview
  9.4.2. Financials
  9.4.3. Product and Services
  9.4.4. Recent Developments
9.5. Access Bio. Inc.
  9.5.1. Overview
  9.5.2. Financials
  9.5.3. Product and Services
  9.5.4. Recent Developments
9.6. Sysmex Europe GmbH
  9.6.1. Overview
  9.6.2. Financials
  9.6.3. Product and Services
  9.6.4. Recent Developments
9.7. Abbott
  9.7.1. Overview
  9.7.2. Financials
  9.7.3. Product and Services
  9.7.4. Recent Developments
9.8. Meridian Bioscience, Europe
  9.8.1. Overview
  9.8.2. Financials
  9.8.3. Product and Services
  9.8.4. Recent Developments
9.9. QuantuMDx Group Ltd.
  9.9.1. Overview
  9.9.2. Financials
  9.9.3. Product and Services
  9.9.4. Recent Developments
9.10. Hemex Health
  9.10.1. Overview
  9.10.2. Financials
  9.10.3. Product and Services
  9.10.4. Recent Developments

10. COMPANY PROFILES

10.1. Motic
10.2. Sight
10.3. BioMérieux SA
10.4. Intellectual Ventures Laboratory
10.5. Access Bio. Inc.
10.6. Sysmex Europe GmbH
10.7. Abbott
10.8. Meridian Bioscience, Europe
10.9. QuantuMDx Group Ltd.
10.10. Hemex Health